Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niloefar Ahmadi Bidakhvidi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Nuclear Medicine|December 27, 2019
18F-FDG PET in Giant Cell ArteritisNiloefar Ahmadi Bidakhvidi, Karolien Goffin, Koen Van Laere, et al.
Clinical Nuclear Medicine|May 25, 2021
68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding ItNiloefar Ahmadi Bidakhvidi, Pieter-Jan Cuyle, Xavier Sagaert, et al.
Clinical Nuclear Medicine|May 23, 2023
Cerebellar Hypermetabolism in a Hodgkin Lymphoma Leads to Diagnosis of Paucisymptomatic Cryptococcus neoformans MeningitisEef Vanerwegen, Niloefar Ahmadi Bidakhvidi, Vibeke K J Vergote, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
<sup>18</sup>F-FDG PET/CT Sheds Light on a Case of HyponatremiaDelphine Gans, Pauline Braet, Niloefar Ahmadi Bidakhvidi, et al.
Clinical Nuclear Medicine|October 15, 2021
Renal Infarction Imaged With [18F]Prostate-Specific Membrane Antigen-1007 PET/CTNiloefar Ahmadi Bidakhvidi, Amaryllis H Van Craenenbroeck, Raymond Oyen, et al.
Cancers|January 11, 2022
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization StrategiesNiloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Extravasation of Therapeutic Radiopharmaceuticals: A Systematic Review and Management ProposalJuanito Gebruers, Christelle Terwinghe, Laura H Graven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2025
Relationship between [<sup>18</sup>F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatmentNiloefar Ahmadi Bidakhvidi, Alexander Giesen, Gaëtan Devos, et al.
European Radiology|August 10, 2021
Prospective comparison of simultaneous [<sup>68</sup>Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancerSander Jentjens, Cindy Mai, Niloefar Ahmadi Bidakhvidi, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|December 27, 2019
18F-FDG PET in Giant Cell ArteritisNiloefar Ahmadi Bidakhvidi, Karolien Goffin, Koen Van Laere, et al.
Clinical Nuclear Medicine|May 25, 2021
68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding ItNiloefar Ahmadi Bidakhvidi, Pieter-Jan Cuyle, Xavier Sagaert, et al.
Clinical Nuclear Medicine|May 23, 2023
Cerebellar Hypermetabolism in a Hodgkin Lymphoma Leads to Diagnosis of Paucisymptomatic Cryptococcus neoformans MeningitisEef Vanerwegen, Niloefar Ahmadi Bidakhvidi, Vibeke K J Vergote, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
<sup>18</sup>F-FDG PET/CT Sheds Light on a Case of HyponatremiaDelphine Gans, Pauline Braet, Niloefar Ahmadi Bidakhvidi, et al.
Clinical Nuclear Medicine|October 15, 2021
Renal Infarction Imaged With [18F]Prostate-Specific Membrane Antigen-1007 PET/CTNiloefar Ahmadi Bidakhvidi, Amaryllis H Van Craenenbroeck, Raymond Oyen, et al.
Cancers|January 11, 2022
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization StrategiesNiloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Extravasation of Therapeutic Radiopharmaceuticals: A Systematic Review and Management ProposalJuanito Gebruers, Christelle Terwinghe, Laura H Graven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2025
Relationship between [<sup>18</sup>F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatmentNiloefar Ahmadi Bidakhvidi, Alexander Giesen, Gaëtan Devos, et al.
European Radiology|August 10, 2021
Prospective comparison of simultaneous [<sup>68</sup>Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancerSander Jentjens, Cindy Mai, Niloefar Ahmadi Bidakhvidi, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
Pageof 2